Status:
COMPLETED
Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia
Lead Sponsor:
Stereotaxis
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
This is a prospective, non-randomized, multi-center clinical case series evaluating the outcomes of the magnetic navigation system in ventricular tachycardia (VT) cases. Subjects will be evaluated acu...
Detailed Description
Catheter ablation of ventricular tachycardia (VT) is greatly facilitated by using a substrate mapping approach - that is, mapping of the left ventricle during sinus or paced rhythm to identify disease...
Eligibility Criteria
Inclusion
- Subject must be between the ages of 18 - 80 years
- Willing to provide prior written informed consent per local ethics committee guidelines
- Subjects must present with ventricular tachycardia, characterized by: history of myocardial scar and spontaneous ventricular tachycardia
- Able to be safely exposed to static magnetic fields
- No in-situ devices are present or any in-situ devices have been verified to be compatible to magnetic fields
Exclusion
- Presence of a mobile ventricular thrombus
- Inability to access the left ventricle
- Subjects must not have any contraindications to short-term anticoagulation
- Subjects must not have a life expectancy of \<1 year due to a medical illness
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00851279
Start Date
June 1 2009
End Date
April 1 2013
Last Update
August 24 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Krannert Institute of Cardiology
Indianapolis, Indiana, United States, 46202
2
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
3
Na Homolce Hospital
Prague, Czechia, 15630
4
Herzzentrum Universitat Leipzig
Leipzig, Germany, 04289